These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2167834)

  • 1. p53 is associated with p34cdc2 in transformed cells.
    Milner J; Cook A; Mason J
    EMBO J; 1990 Sep; 9(9):2885-9. PubMed ID: 2167834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.
    Addison C; Jenkins JR; Stürzbecher HW
    Oncogene; 1990 Mar; 5(3):423-6. PubMed ID: 2156209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
    Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
    Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53.
    Scheidtmann KH; Haber A
    J Virol; 1990 Feb; 64(2):672-9. PubMed ID: 2153233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic stabilization of p53 in SV40-transformed cells correlates with expression of the transformed phenotype but is independent from complex formation with SV40 large T antigen.
    Deppert W; Steinmayer T
    Curr Top Microbiol Immunol; 1989; 144():77-83. PubMed ID: 2551594
    [No Abstract]   [Full Text] [Related]  

  • 7. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
    Bischoff JR; Friedman PN; Marshak DR; Prives C; Beach D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4766-70. PubMed ID: 2141171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controls of cell proliferation in yeast and animals.
    Norbury C; Nurse P
    Ciba Found Symp; 1990; 150():168-77; discussion 177-83. PubMed ID: 2197066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.
    Milner J; Chan YS; Medcalf EA; Wang Y; Eckhart W
    Oncogene; 1993 Jul; 8(7):2001-8. PubMed ID: 8510941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping and regulation of the association of p53 with p34cdc2.
    Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
    Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of human papillomavirus types 16 and 18 E6 proteins with p53.
    Werness BA; Levine AJ; Howley PM
    Science; 1990 Apr; 248(4951):76-9. PubMed ID: 2157286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53.
    Scheidtmann KH
    Curr Top Microbiol Immunol; 1989; 144():85-8. PubMed ID: 2551595
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen.
    Oshima J; Steinmann KE; Campisi J; Schlegel R
    Oncogene; 1993 Nov; 8(11):2987-93. PubMed ID: 8414501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells.
    van den Heuvel SJ; van Laar T; Kast WM; Melief CJ; Zantema A; van der Eb AJ
    EMBO J; 1990 Aug; 9(8):2621-9. PubMed ID: 2142453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.
    Pérez L; Paasinen A; Schnierle B; Käch S; Senften M; Ballmer-Hofer K
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8113-7. PubMed ID: 7690142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a simian virus 40 mutant T antigen substituted in the hydrophobic region: defective ATPase and oligomerization activities and altered phosphorylation accompany an inability to complex with cellular p53.
    Tack LC; Cartwright CA; Wright JH; Eckhart W; Peden KW; Srinivasan A; Pipas JM
    J Virol; 1989 Aug; 63(8):3362-7. PubMed ID: 2545911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of p53 protein expression during cellular transformation with simian virus 40.
    Deppert W; Haug M; Steinmayer T
    Mol Cell Biol; 1987 Dec; 7(12):4453-63. PubMed ID: 2830494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases phosphorylate nuclear lamins and display sequence specificity overlapping that of mitotic protein kinase p34cdc2.
    Peter M; Sanghera JS; Pelech SL; Nigg EA
    Eur J Biochem; 1992 Apr; 205(1):287-94. PubMed ID: 1555589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210.
    Hamaguchi JR; Tobey RA; Pines J; Crissman HA; Hunter T; Bradbury EM
    J Cell Biol; 1992 Jun; 117(5):1041-53. PubMed ID: 1533642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.